Direxion Daily S&P Biotech Bull 3x Shares (NYSEARCA:LABU – Get Free Report)’s stock price rose 8.1% on Wednesday . The company traded as high as $200.50 and last traded at $199.59. 197,844 shares traded hands during trading, a decline of 68% from the average daily volume of 619,477 shares. The stock had previously closed at $184.63.
Direxion Daily S&P Biotech Bull 3x Shares Trading Up 3.2%
The firm has a fifty day moving average price of $183.34 and a 200-day moving average price of $170.98.
Institutional Investors Weigh In On Direxion Daily S&P Biotech Bull 3x Shares
Large investors have recently bought and sold shares of the company. Tower Research Capital LLC TRC increased its stake in Direxion Daily S&P Biotech Bull 3x Shares by 664.7% in the third quarter. Tower Research Capital LLC TRC now owns 58,171 shares of the company’s stock valued at $5,445,000 after acquiring an additional 50,564 shares during the last quarter. Squarepoint Ops LLC boosted its holdings in shares of Direxion Daily S&P Biotech Bull 3x Shares by 33.2% in the 2nd quarter. Squarepoint Ops LLC now owns 161,146 shares of the company’s stock valued at $9,171,000 after purchasing an additional 40,157 shares in the last quarter. JPMorgan Chase & Co. bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at $3,208,000. Virtu Financial LLC bought a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares in the 3rd quarter valued at $1,757,000. Finally, IvyRock Asset Management HK Ltd acquired a new position in shares of Direxion Daily S&P Biotech Bull 3x Shares during the 3rd quarter worth $768,000.
About Direxion Daily S&P Biotech Bull 3x Shares
The Direxion Daily S&P Biotech Bull 3X Shares (LABU) is an exchange-traded fund that is based on the S&P Biotechnology Select Industry index. The fund provides daily 3 times exposure to the S&P Biotechnology Select Industry Index. LABU was launched on May 28, 2015 and is managed by Direxion.
Read More
- Five stocks we like better than Direxion Daily S&P Biotech Bull 3x Shares
- Credo Technologies Accelerates AI—Its Stock Price Will Follow
- Qualcomm Goes All-In: The $10B Bet to Crush NVIDIA
- Jabil Just Gave Investors a Stronger Reason to Buy the Dip
- CarMax In Reverse? Why You Should Buy Now Before the Big Catalysts Emerge
Receive News & Ratings for Direxion Daily S&P Biotech Bull 3x Shares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Direxion Daily S&P Biotech Bull 3x Shares and related companies with MarketBeat.com's FREE daily email newsletter.
